Gene-Chemical Interaction Annotations Click to see Annotation Detail View
Object Symbol | Species | Term | Qualifier | Evidence | With | Reference | Notes | Source | Original Reference(s) | ZSCAN20 | Human | (-)-demecolcine | increases expression | EXP | | 6480464 | Demecolcine results in increased expression of ZSCAN20 mRNA | CTD | PMID:23649840 | ZSCAN20 | Human | 17beta-estradiol | multiple interactions | EXP | | 6480464 | [Estradiol co-treated with Bucladesine co-treated with Medroxyprogesterone Acetate] results in increased expression of ZSCAN20 mRNA | CTD | PMID:20823114 | ZSCAN20 | Human | 2,3,7,8-tetrachlorodibenzodioxine | affects expression | ISO | Zscan20 (Mus musculus) | 6480464 | Tetrachlorodibenzodioxin affects the expression of ZSCAN20 mRNA | CTD | PMID:24058054 | ZSCAN20 | Human | 2,3,7,8-tetrachlorodibenzodioxine | increases expression | ISO | Zscan20 (Rattus norvegicus) | 6480464 | Tetrachlorodibenzodioxin results in increased expression of ZSCAN20 mRNA | CTD | PMID:33387578 | ZSCAN20 | Human | 2-palmitoylglycerol | increases expression | EXP | | 6480464 | 2-palmitoylglycerol results in increased expression of ZSCAN20 mRNA | CTD | PMID:37199045 | ZSCAN20 | Human | acrylamide | increases expression | EXP | | 6480464 | Acrylamide results in increased expression of ZSCAN20 mRNA | CTD | PMID:32763439 | ZSCAN20 | Human | amiodarone | increases expression | EXP | | 6480464 | Amiodarone results in increased expression of ZSCAN20 mRNA | CTD | PMID:19774075 | ZSCAN20 | Human | amphetamine | decreases expression | ISO | Zscan20 (Rattus norvegicus) | 6480464 | Amphetamine results in decreased expression of ZSCAN20 mRNA | CTD | PMID:30779732 | ZSCAN20 | Human | benzo[a]pyrene | decreases methylation | EXP | | 6480464 | Benzo(a)pyrene results in decreased methylation of ZSCAN20 5' UTR and Benzo(a)pyrene results in decreased methylation of ZSCAN20 promoter | CTD | PMID:27901495 | ZSCAN20 | Human | benzo[a]pyrene | increases methylation | ISO | Zscan20 (Mus musculus) | 6480464 | Benzo(a)pyrene results in increased methylation of ZSCAN20 intron | CTD | PMID:27901495 | ZSCAN20 | Human | bisphenol A | affects methylation | ISO | Zscan20 (Mus musculus) | 6480464 | bisphenol A affects the methylation of ZSCAN20 promoter | CTD | PMID:27334623 | ZSCAN20 | Human | bisphenol A | decreases expression | EXP | | 6480464 | bisphenol A results in decreased expression of ZSCAN20 mRNA | CTD | PMID:36232920 | ZSCAN20 | Human | bisphenol A | decreases methylation | ISO | Zscan20 (Mus musculus) | 6480464 | bisphenol A results in decreased methylation of ZSCAN20 promoter | CTD | PMID:27312807 | ZSCAN20 | Human | bucladesine | multiple interactions | EXP | | 6480464 | [Estradiol co-treated with Bucladesine co-treated with Medroxyprogesterone Acetate] results in increased expression of ZSCAN20 mRNA | CTD | PMID:20823114 | ZSCAN20 | Human | CGP 52608 | multiple interactions | EXP | | 6480464 | CGP 52608 promotes the reaction [RORA protein binds to ZSCAN20 gene] | CTD | PMID:28238834 | ZSCAN20 | Human | CU-O LINKAGE | increases expression | EXP | | 6480464 | cupric oxide results in increased expression of ZSCAN20 mRNA | CTD | PMID:22077320 | ZSCAN20 | Human | dorsomorphin | multiple interactions | EXP | | 6480464 | [NOG protein co-treated with Valproic Acid co-treated with dorsomorphin co-treated with 4-(5-benzo(1 and 3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in decreased expression of ZSCAN20 mRNA | CTD | PMID:27188386 | ZSCAN20 | Human | doxorubicin | decreases expression | EXP | | 6480464 | Doxorubicin results in decreased expression of ZSCAN20 mRNA | CTD | PMID:29803840 | ZSCAN20 | Human | endosulfan | decreases expression | ISO | Zscan20 (Rattus norvegicus) | 6480464 | Endosulfan results in decreased expression of ZSCAN20 mRNA | CTD | PMID:29391264 | ZSCAN20 | Human | FR900359 | increases phosphorylation | EXP | | 6480464 | FR900359 results in increased phosphorylation of ZSCAN20 protein | CTD | PMID:37730182 | ZSCAN20 | Human | gentamycin | decreases expression | ISO | Zscan20 (Rattus norvegicus) | 6480464 | Gentamicins results in decreased expression of ZSCAN20 mRNA | CTD | PMID:33387578 | ZSCAN20 | Human | medroxyprogesterone acetate | multiple interactions | EXP | | 6480464 | [Estradiol co-treated with Bucladesine co-treated with Medroxyprogesterone Acetate] results in increased expression of ZSCAN20 mRNA | CTD | PMID:20823114 | ZSCAN20 | Human | methyl methanesulfonate | increases expression | EXP | | 6480464 | Methyl Methanesulfonate results in increased expression of ZSCAN20 mRNA | CTD | PMID:23649840 | ZSCAN20 | Human | methylmercury chloride | decreases expression | EXP | | 6480464 | methylmercuric chloride results in decreased expression of ZSCAN20 mRNA | CTD | PMID:28001369 | ZSCAN20 | Human | pentanal | decreases expression | EXP | | 6480464 | pentanal results in decreased expression of ZSCAN20 mRNA | CTD | PMID:26079696 | ZSCAN20 | Human | SB 431542 | multiple interactions | EXP | | 6480464 | [NOG protein co-treated with Valproic Acid co-treated with dorsomorphin co-treated with 4-(5-benzo(1 and 3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in decreased expression of ZSCAN20 mRNA | CTD | PMID:27188386 | ZSCAN20 | Human | sunitinib | decreases expression | EXP | | 6480464 | Sunitinib results in decreased expression of ZSCAN20 mRNA | CTD | PMID:31533062 | ZSCAN20 | Human | thioacetamide | increases expression | ISO | Zscan20 (Rattus norvegicus) | 6480464 | Thioacetamide results in increased expression of ZSCAN20 mRNA | CTD | PMID:34492290 | ZSCAN20 | Human | titanium dioxide | decreases expression | ISO | Zscan20 (Mus musculus) | 6480464 | titanium dioxide results in decreased expression of ZSCAN20 mRNA | CTD | PMID:29264374 | ZSCAN20 | Human | valproic acid | affects expression | ISO | Zscan20 (Mus musculus) | 6480464 | Valproic Acid affects the expression of ZSCAN20 mRNA | CTD | PMID:17963808 | ZSCAN20 | Human | valproic acid | decreases expression | EXP | | 6480464 | Valproic Acid results in decreased expression of ZSCAN20 mRNA | CTD | PMID:23179753 and PMID:26272509 | ZSCAN20 | Human | valproic acid | multiple interactions | EXP | | 6480464 | [NOG protein co-treated with Valproic Acid co-treated with dorsomorphin co-treated with 4-(5-benzo(1 and 3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in decreased expression of ZSCAN20 mRNA | CTD | PMID:27188386 | |